HuGE Literature Finder
Records
1
-
30
| Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma. British journal of cancer 2022 Jan . Ye Shuang, Li Qin, Wu Yutuan, Jiang Wei, Zhou Shuling, Zhou Xiaoyan, Yang Wentao, Tu Xiaoyu, Shan Boer, Huang Shenglin, Yang Huiju |
| Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas. Cancers 2021 Feb 13 (4): . Jin Meihua, Song Dong Eun, Ahn Jonghwa, Song Eyun, Lee Yu-Mi, Sung Tae-Yon, Kim Tae Yong, Kim Won Bae, Shong Young Kee, Jeon Min Ji, Kim Won |
| Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct. Cancers 2020 Dec 13 (1): . Sorgini Alana, Kim Hugh Andrew Jinwook, Zeng Peter Y F, Shaikh Mushfiq Hassan, Mundi Neil, Ghasemi Farhad, Di Gravio Eric, Khan Halema, MacNeil Danielle, Khan Mohammed Imran, Mendez Adrian, Yoo John, Fung Kevin, Lang Pencilla, Palma David A, Mymryk Joe S, Barrett John W, Patel Krupal B, Boutros Paul C, Nichols Anthony |
| Akt1 genetic variants confer increased susceptibility to thyroid cancer. Endocrine connections 2020 Oct . Crezee Thomas, Petrulea Mirela, Piciu Doina, Jaeger Martin, Smit Jan Wa, Plantinga Theo S, Georgescu Carmen E, Netea-Maier Roma |
| Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. Oncogene 2020 Oct . von Felden Johann, Craig Amanda J, Garcia-Lezana Teresa, Labgaa Ismail, Haber Philipp K, D'Avola Delia, Asgharpour Amon, Dieterich Douglas, Bonaccorso Antoinette, Torres-Martin Miguel, Sia Daniela, Sung Max W, Tabrizian Parissa, Schwartz Myron, Llovet Josep M, Villanueva Augus |
| Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
| Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Jun . Sun Xiangjie, Zuo Ke, Yao Qianlan, Zhou Shuling, Shui Ruohong, Xu Xiaoli, Bi Rui, Yu Baohua, Cheng Yufan, Tu Xiaoyu, Lu Hongfen, Yang Went |
| Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells. Carcinogenesis 2020 Mar . Nishimura Sadaaki, Yashiro Masakazu, Sera Tomohiro, Yamamoto Yurie, Kushitani Yukako, Sugimoto Atsushi, Kushiyama Shuhei, Togano Shingo, Kuroda Kenji, Okuno Tomohisa, Murakami Yoshiki, Ohira Masaic |
| Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer. Journal of cancer research and clinical oncology 2019 Oct . Xu Yiquan, Huang Yina, Weng Lihong, Zheng Jiankun, Huang Yi, Lin Ying, Zhao Yunan, Li Hongru, Chen Yushe |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients. BMC cancer 2019 Aug 19 (1): 818. Meng Pei, Wei Jiacong, Geng Yiqun, Chen Shaobin, Terpstra Miente Martijn, Huang Qiongyi, Zhang Qian, Su Zuoqing, Yu Wanchun, Su Min, Kok Klaas, van den Berg Anke, Gu Jia |
| Molecular characterization of metaplastic breast carcinoma via next-generation sequencing. Human pathology 2019 Apr 86 85-92. Zhai Jing, Giannini Gabriel, Ewalt Mark D, Zhang Elizabeth Y, Invernizzi Marta, Niland Joyce, Lai Lily |
| Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma. Head & neck 2019 Feb 41 (2): 423-428. Smith Joshua D, Birkeland Andrew C, Rosko Andrew J, Hoesli Rebecca C, Foltin Susan K, Swiecicki Paul, Mierzwa Michelle, Chinn Steven B, Shuman Andrew G, Malloy Kelly M, Casper Keith A, McLean Scott A, Wolf Gregory T, Bradford Carol R, Prince Mark E, Brenner John Chad, Spector Matthew |
| Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British journal of cancer 2018 Sep 119 (6): 707-712. Bellmunt Joaquim, Lalani Aly-Khan A, Jacobus Sussana, Wankowicz Stephanie A, Polacek Laura, Takeda David Y, Harshman Lauren C, Wagle Nikhil, Moreno Irene, Lundgren Kevin, Bossé Dominick, Van Allen Eliezer M, Choueiri Toni K, Rosenberg Jonathan |
| Detection of Molecular Alterations in Taiwanese Patients with Medullary Thyroid Cancer Using Whole-Exome Sequencing. Endocrine pathology 2018 Aug . Chang Ya-Sian, Chang Chun-Chi, Huang Hsi-Yuan, Lin Chien-Yu, Yeh Kun-Tu, Chang Jan-Gow |
| The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases. Histopathology 2018 Jul . Urano Makoto, Hirai Hideaki, Tada Yuichiro, Kawakita Daisuke, Shimura Tomotaka, Tsukahara Kiyoaki, Kano Satoshi, Ozawa Hiroyuki, Okami Kenji, Sato Yuichiro, Fushimi Chihiro, Shimizu Akira, Takase Soichiro, Okada Takuro, Sato Hiroki, Imanishi Yorihisa, Otsuka Kuninori, Watanabe Yoshihiro, Sakai Akihiro, Ebisumoto Koji, Togashi Takafumi, Ueki Yushi, Ota Hisayuki, Sato Yukiko, Saigusa Natsuki, Nakaguro Masato, Hanazawa Toyoyuki, Nagao Toshita |
| Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations. Scientific reports 2018 Jun 8 (1): 9204. Fritsche-Guenther Raphaela, Zasada Christin, Mastrobuoni Guido, Royla Nadine, Rainer Roman, Roßner Florian, Pietzke Matthias, Klipp Edda, Sers Christine, Kempa Stef |
| Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway. Oncotarget 2018 Mar 9 (22): 16074-16086. Adimonye Anthony, Stankiewicz Elzbieta, Kudahetti Sakunthala, Trevisan Giorgia, Tinwell Brendan, Corbishley Cathy, Lu Yong-Jie, Watkin Nick, Berney Dani |
| Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women. Pathology, research and practice 2018 Mar . Khan Farhan, Esnakula Ashwini, Ricks-Santi Luisel J, Zafar Rabia, Kanaan Yasmine, Naab Tamm |
| Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. British journal of cancer 2018 Mar . Lau David K, Tay Rebecca Y, Yeung Yvonne H, Chionh Fiona, Mooi Jennifer, Murone Carmel, Skrinos Effie, Price Timothy J, Mariadason John M, Tebbutt Niall |
| Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI. Oncology 2018 Feb . Kieler Markus, Müllauer Leonhard, Koperek Oskar, Bianconi Daniela, Unseld Matthias, Raderer Markus, Prager Gerald |
| Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. European journal of cancer (Oxford, England : 1990) 2018 Jan 91 47-55. Dubot C, Bernard V, Sablin M P, Vacher S, Chemlali W, Schnitzler A, Pierron G, Ait Rais K, Bessoltane N, Jeannot E, Klijanienko J, Mariani O, Jouffroy T, Calugaru V, Hoffmann C, Lesnik M, Badois N, Berger F, Le Tourneau C, Kamal M, Bieche |
| Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. European journal of cancer (Oxford, England : 1990) 2018 03 92 1-10. Verlingue Loic, Hollebecque Antoine, Lacroix Ludovic, Postel-Vinay Sophie, Varga Andrea, El Dakdouki Yolla, Baldini Capucine, Balheda Rastilav, Gazzah Anas, Michot Jean-Marie, Marabelle Aurélien, Mir Olivier, Arnedos Monica, Rouleau Etienne, Solary Eric, De Baere Thierry, Angevin Eric, Armand Jean-Pierre, Michiels Stefan, André Fabrice, Deutsch Eric, Scoazec Jean-Yves, Soria Jean-Charles, Massard Christop |
| Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
| Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia. British journal of cancer 2017 Jun 117 (1): 136-143. Chakrabarty Sanjiban, Varghese Vinay Koshy, Sahu Pranoy, Jayaram Pradyumna, Shivakumar Bhadravathi M, Pai Cannanore Ganesh, Satyamoorthy Kapaet |
| A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors. Investigational new drugs 2016 Dec . Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari |
| Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European urology focus 2016 Dec 2 (6): 633-639. de Velasco Guillermo, Gray Kathryn P, Hamieh Lana, Urun Yuksel, Carol Hallie A, Fay Andre P, Signoretti Sabina, Kwiatkowski David J, McDermott David F, Freedman Matthew, Pomerantz Mark M, Choueiri Toni |
| Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. Scientific reports 2016 Nov 6 37576. Guo Qiaojuan, Lu Tianzhu, Chen Yan, Su Ying, Zheng Yuhong, Chen Zeng, Chen Chao, Lin Shaojun, Pan Jianji, Yuan Xiangl |
| Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. European urology 2016 Oct . Hsieh James J, Chen David, Wang Patricia I, Marker Mahtab, Redzematovic Almedina, Chen Ying-Bei, Selcuklu S Duygu, Weinhold Nils, Bouvier Nancy, Huberman Kety H, Bhanot Umesh, Chevinsky Michael S, Patel Parul, Pinciroli Patrizia, Won Helen H, You Daoqi, Viale Agnes, Lee William, Hakimi A Ari, Berger Michael F, Socci Nicholas D, Cheng Emily H, Knox Jennifer, Voss Martin H, Voi Maurizio, Motzer Robert |
| Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups. Cancer immunology research 2016 Aug . De Velasco Guillermo, Miao Diana D, Voss Martin H, Hakimi A Ari, Hsieh James J, Tannir Nizar M, Tamboli Pheroze, Appleman Leonard J, Rathmell W Kimryn, Van Allen Eliezer, Choueiri Toni |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 18, 2022
- Content source: